Lord’s Mark Industries Ltd, one of India’s fastest-growing diversified conglomerates, has achieved a significant milestone by becoming one of the companies to secure US FDA registrations covering 153 orthosurgical products, setting a new benchmark for Indian medical device manufacturers. This achievement marks an important step in the company’s ongoing journey to establish itself as a globally trusted healthcare manufacturing partner and highlights India’s growing capability to deliver regulated medical products at international standards.
All the orthosurgical products are manufactured within Lord’s Mark Industries’ globally aligned manufacturing ecosystem, built to meet the highest standards of regulatory compliance and operational excellence. The company’s manufacturing facilities have been developed with a strong focus on quality, scalability, and regulatory readiness, enabling consistent production of medical devices that meet stringent global requirements. The facility operates on internationally benchmarked production protocols, supported by robust quality management systems, validated manufacturing processes, end-to-end traceability, and a comprehensive compliance framework designed to meet US FDA requirements. These systems reflect the company’s long-term commitment to building export-ready, world-class medical manufacturing capabilities from India while ensuring patient safety and product reliability.
The US FDA-listed portfolio covers a broad range of orthosurgical products, demonstrating the depth and diversity of Lord’s Mark Industries’ manufacturing capabilities. The portfolio includes orthopaedic braces, spinal and cervical supports, Lord’s Activeguard knee and ankle braces, Lord’s Activeguard compression stockings, Lord’s Activeguard Hernia belts, Lord’s Activeguard Elastic knee support, Lord’s Activeguard Orthosis Soft & Hard cervical collar, Lord’s Activeguard Chin support belt, Lord’s Joywipes Disinfectant & Cleansing wipes, Lord’s Activeguard Tennis Elbow Support, Lord’s Magic Elastic Adhesive Bandage, Lord’s Activeguard Abdominal Support, Lord’s Activeguard ARS Pad, Lord’s Activeguard Travel Neck Pillow, and a range of post-surgical rehabilitation products. Together, these products address diverse clinical needs across orthopaedic care, injury management, recovery support, and post-operative rehabilitation, strengthening the company’s position across multiple healthcare segments.
Commenting on the achievement, Sachidanand Upadhyay, Managing Director, Lord’s Mark Industries Ltd, said, “This milestone goes beyond regulatory recognition. It reinforces our belief that world-class medical devices can be designed, manufactured, and regulated from India at global scale. Being one of the company to secure US FDA recognition for 153 orthosurgical products reflects the strength of our Silvassa manufacturing platform, our regulatory discipline, and our long-term vision to position India as a trusted source of globally compliant healthcare solutions.” His remarks underline the company’s focus on building sustainable manufacturing excellence supported by strong governance and compliance-led growth.
This milestone significantly strengthens Lord’s Mark Industries’ access to highly regulated international markets, including the United States, Latin America, and the Middle East. As global healthcare systems increasingly seek cost-effective yet regulation-compliant orthopaedic solutions, the company is well positioned to expand institutional supplies, hospital partnerships, and distributor-led exports. Through its US-based subsidiary, Lord’s Mark Global LLC, Lord’s Mark Industries joins a select group of Indian healthcare manufacturers with established US FDA recognition. This achievement further reinforces India’s growing presence in the global medtech value chain and supports the company’s broader strategy of expanding its international footprint while contributing to the global healthcare ecosystem.
For More Details Visit :- https://lordsmark.com/
Disclaimer: This is a sponsored article. All possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; however Outlookindia.com does not take any liability for the same. Using of any information provided in the article is solely at the viewers’ discretion.
